Categories Earnings, LATEST, Technology
Micron (MU) stock jumps after Q2 earnings, revenue beat view; guides Q3
Earnings of chipmaker Micron Technology Inc. (NASDAQ: MU) declined in the second quarter of 2020, continuing the recent trend. The bottom-line was affected by a dip in revenues amid the persistent slowdown in the demand for memory chips.
Towards the end of the quarter, the business was negatively impacted by disruptions caused by the covid-19 outbreak, which is expected to weigh on performance in the coming months.
Stock Gains
The results, meanwhile, topped the Street view and the company’s stock gained immediately after the announcement on Wednesday ravening. The market was also encouraged by the better-than -expected third-quarter guidance.
Earnings, adjusted for special items, dropped to $0.45 per share from $1.71 per share in the second quarter of 2019. Unadjusted net income was $405 million or $0.36 per share, compared to $1.6 billion or $1.41 per share last year. Earnings, however, came in above analysts’ forecast.
Revenue Dips
Dragging down the bottom-line, revenues dropped 18% annually to $4.8 billion during the three-month period, but far exceeded the market’s prediction. All the four business segments registered double-digit fall in revenues during the quarter.
[irp posts=”51592″]
“Micron delivered solid second quarter results and revenue at the high end of the guidance range, despite the unfolding COVID-19 pandemic. I am grateful to our team for the excellent business execution we have achieved during this unprecedented situation,” said CEO Sanjay Mehrotra.
Guidance
In the quarter ending May 2020, which will be period of great uncertainty due to the coronavirus crisis, adjusted earnings are expected to come in at $0.55 per share, plus or minus $0.15. Unadjusted profit is expected to be $0.41 per share, plus or minus $0.15. The management is currently looking for third-quarter revenues in the range of $4.6 billion to $5.2 billion.
Micron’s stock has dropped 21% since the beginning of the year and 16% in the past one month. The stock closed Wednesday’s regular trading lower, but bounced back during the after-hours session.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on